Avalo Therapeutics, Inc. · NASDAQ:AVTX

Doyle Mittie received 43,500 Avalo Therapeutics, Inc. shares as an award (Form 4)

Traded May 21, 2026 · Filed May 26, 2026

On May 21, 2026, Doyle Mittie (Chief Medical Officer) received 43,500 Avalo Therapeutics, Inc. shares as an award, leaving 47,122 shares. Filed May 26, 2026 (Form 4).

Awarded
43,500 shares
Holding after
47,122 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockAward43,50047,122Direct

Source

View original at SEC

Related